BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32827331)

  • 1. High infiltration of B cells in tertiary lymphoid structures, TCR oligoclonality, and neoantigens are part of esophageal squamous cell carcinoma microenvironment.
    Barros LRC; Souza-Santos PT; Pretti MAM; Vieira GF; Bragatte MAS; Mendes MFA; De Freitas MV; Scherer NM; De Oliveira IM; Rapozo DCM; Fernandes PV; Simão TA; Soares-Lima SC; Boroni M; Ribeiro Pinto LF; Bonamino MH
    J Leukoc Biol; 2020 Oct; 108(4):1307-1318. PubMed ID: 32827331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
    Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
    Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
    Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
    J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
    Zheng Y; Chen Z; Han Y; Han L; Zou X; Zhou B; Hu R; Hao J; Bai S; Xiao H; Li WV; Bueker A; Ma Y; Xie G; Yang J; Chen S; Li H; Cao J; Shen L
    Nat Commun; 2020 Dec; 11(1):6268. PubMed ID: 33293583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy.
    Zhang C; Palashati H; Tan Q; Ku W; Miao Y; Xiong H; Lu Z
    Carcinogenesis; 2018 Dec; 39(11):1389-1398. PubMed ID: 30202955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
    Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
    Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment.
    Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the immune infiltrate and patient outcomes in esophageal cancer.
    Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
    Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD86
    Wennhold K; Thelen M; Lehmann J; Schran S; Preugszat E; Garcia-Marquez M; Lechner A; Shimabukuro-Vornhagen A; Ercanoglu MS; Klein F; Thangarajah F; Eidt S; Löser H; Bruns C; Quaas A; von Bergwelt-Baildon M; Schlößer HA
    Cancer Immunol Res; 2021 Sep; 9(9):1098-1108. PubMed ID: 34155067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.
    Quan H; Fang L; Pan H; Deng Z; Gao S; Liu O; Wang Y; Hu Y; Fang X; Yao Z; Guo F; Lu R; Xia K; Tang Z
    Int J Cancer; 2016 Jun; 138(12):2952-62. PubMed ID: 26815146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
    Yuan X; Li Y; Zhang AZ; Jiang CH; Li FP; Xie YF; Li JF; Liang WH; Zhang HJ; Liu CX; Pang LJ; Shen XH; Li F; Hu JM
    Aging (Albany NY); 2020 Dec; 13(2):2049-2072. PubMed ID: 33323552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
    Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
    Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures.
    Chen L; Oke T; Siegel N; Cojocaru G; Tam AJ; Blosser RL; Swailes J; Ligon JA; Lebid A; Morris C; Levin A; Rhee DS; Johnston FM; Greer JB; Meyer CF; Ladle BH; Thompson ED; Montgomery EA; Choi W; McConkey DJ; Anders RA; Pardoll DM; Llosa NJ
    Clin Cancer Res; 2020 Aug; 26(15):4018-4030. PubMed ID: 32332015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.
    Pineda S; López de Maturana E; Yu K; Ravoor A; Wood I; Malats N; Sirota M
    Front Immunol; 2021; 12():730746. PubMed ID: 34630409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.
    Shen YC; Hsu CL; Jeng YM; Ho MC; Ho CM; Yeh CP; Yeh CY; Hsu MC; Hu RH; Cheng AL
    J Hepatol; 2020 Mar; 72(3):489-497. PubMed ID: 31634533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients.
    Daiko H; Marafioti T; Fujiwara T; Shirakawa Y; Nakatsura T; Kato K; Puccio I; Hikichi T; Yoshimura S; Nakagawa T; Furukawa M; Stoeber K; Nagira M; Ide N; Kojima T
    Cancer Immunol Immunother; 2020 Nov; 69(11):2247-2257. PubMed ID: 32500232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
    Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
    Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.